Phosphodiesterase-5 inhibitors in the treatment of lower urinary tract symptoms and benign prostatic hyperplasia - Giannitsas, K; Mitropoulos, D; Kostantinopoulos, A (Expert Opin Pharmacother, 2008)
et al.